ZHENG; Zhongli

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHENG; Zhongli.The latest application filed is for "wound healing composition".

Company Profile

2.9.14

ZHENG; Zhongli - Ipswich MA
Zheng; Zhongli - Lexington MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Wound Healing Composition App 20210236446 - ZHENG; Zhongli ; et al.	2021-08-05
Wound healing composition Grant 10,980,762 - Zheng , et al. April 20, 2	2021-04-20
Wound Healing Composition App 20190247352 - ZHENG; Zhongli ; et al.	2019-08-15
Pyrazolopyridines and methods of making and using the same Grant 7,691,865 - Lee , et al. April 6, 2	2010-04-06
Tri-substituted heteroaryls and methods of making and using the same Grant 7,612,094 - Lee , et al. November 3, 2	2009-11-03
Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications App 20070249682 - Zheng; Zhongli ; et al.	2007-10-25
CD40:CD154 binding interrupter compounds and use thereof to treat immunological complications Grant 7,173,046 - Zheng , et al. February 6, 2	2007-02-06
Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins App 20060172346 - Zheng; Zhongli ; et al.	2006-08-03
Pyrazolopyridines and methods of making and using the same App 20060106033 - Lee; Wen-Cherng ; et al.	2006-05-18
Tri-substituted heteroaryls and methods of making and using the same App 20060063809 - Lee; Wen-Cherng ; et al.	2006-03-23
Cell adhesion inhibitors App 20060030553 - Zheng; Zhongli ; et al.	2006-02-09
Cell adhesion inhibitors Grant 6,949,534 - Zheng , et al. September 27, 2	2005-09-27
Ligand analysis App 20050064510 - Akyuz, Can D. ; et al.	2005-03-24
Method of screening for target ligands App 20050059038 - Adams, Steven P. ; et al.	2005-03-17
Novel CD40 : CD154 binding interruptor compounds and use thereof to treat immunological complications App 20040067982 - Zheng, Zhongli ; et al.	2004-04-08
Cell adhesion inhibitors App 20040053907 - Zheng, Zhongli ; et al.	2004-03-18
Cell adhesion inhibitors Grant 6,686,350 - Zheng , et al. February 3, 2	2004-02-03
Co-crystal structure of monoclonal antibody 5C8 and CD154, and use thereof in drug design App 20040006208 - Karpusas, Michael ; et al.	2004-01-08
Methods for designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteins App 20030235861 - Zheng, Zhongli ; et al.	2003-12-25
Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses App 20030114514 - Zheng, Zhongli ; et al.	2003-06-19
Molecular model for VLA-4 inhibitors Grant 6,552,216 - Singh , et al. April 22, 2	2003-04-22
Sialyl Le.sup.x analogues as inhibitors of cellular adhesion Grant 5,811,404 - De Frees , et al. September 22, 1	1998-09-22
Sialyl Le.sup.x analogues as inhibitors of cellular adhesion Grant 5,604,207 - DeFrees , et al. February 18, 1	1997-02-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.